🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the plasma pharmacokinetic of padse...
Status
Completed
Location
Up0053 001
Start Date
2019-07-09
Trial ID
NCT04013191
Treatments Being Tested
The purpose of the study is to investigate the pharmacokinetics (PK) of pad...
Status
Completed
Location
Up0083 001
Start Date
2019-09-30
Trial ID
NCT04075409
Treatments Being Tested
The purpose of the study is to characterize the dose-response relationship ...
Status
Completed
Location
Ep0091 839
Start Date
2018-02-12
Trial ID
NCT03373383
Treatments Being Tested
The purpose of the study in Part 1, is to evaluate (under fasted conditions...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-02-24
Trial ID
NCT04283136
The purpose of this study is to evaluate and compare the Pharmacokinetics (...
Status
Completed
Location
Up0057 001
Start Date
2018-03-27
Trial ID
NCT03480243
Treatments Being Tested
The purpose of the study is to evaluate the long-term safety and tolerabili...
Status
Terminated
Location
Ep0093 839
Start Date
2018-08-27
Trial ID
NCT03370120
Treatments Being Tested
The purpose of the study is to evaluate the effects on cardiac repolarizati...
Status
Terminated
Location
Up0050 001
Start Date
2019-10-23
Trial ID
NCT04126343
Treatments Being Tested
The purpose of the study is to investigate the effect of steady-state padse...
Status
Terminated
Location
Up0035 001
Start Date
2019-10-23
Trial ID
NCT04131517
Treatments Being Tested
The purpose of the study is to evaluate the effect of stable coadministered...
Status
Completed
Location
Up0070 101
Start Date
2018-09-18
Trial ID
NCT03695094
Treatments Being Tested
The purpose of the study is to evaluate the plasma pharmacokinetic (PK), sa...
Status
Terminated
Location
Up0056 004
Start Date
2019-10-28
Trial ID
NCT04136444
Treatments Being Tested